Mydecine Innovations Group (STU:0NF0) Other Operating Expense : €2.36 Mil (TTM As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Mydecine Innovations Group Other Operating Expense?

Mydecine Innovations Group's Other Operating Expense for the three months ended in Sep. 2023 was €0.39 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was €2.36 Mil.

Mydecine Innovations Group's quarterly Other Operating Expense declined from Mar. 2023 (€1.39 Mil) to Jun. 2023 (€0.09 Mil) but then increased from Jun. 2023 (€0.09 Mil) to Sep. 2023 (€0.39 Mil).

Mydecine Innovations Group's annual Other Operating Expense increased from Dec. 2020 (€1.81 Mil) to Dec. 2021 (€3.40 Mil) but then declined from Dec. 2021 (€3.40 Mil) to Dec. 2022 (€2.07 Mil).

Mydecine Innovations Group Other Operating Expense Historical Data

The historical data trend for Mydecine Innovations Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Other Operating Expense Chart

Mydecine Innovations Group Annual Data

Trend

Dec13

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

0.39

0.15

1.81

3.40

2.07

Mydecine Innovations Group Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Operating Expense	Get a 7-Day Free Trial															0.08	0.49	1.39	0.09	0.39

Mydecine Innovations Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.36 Mil.

Mydecine Innovations Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mydecine Innovations Group (STU:0NF0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (STU:0NF0) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

MYCOF:USA MYIG:UK MYCO:Canada

Address

789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (STU:0NF0) Headlines

No Headlines